These C/Q@ZIF-8-HA nanozymes, while efficiently targeting tumor cells, significantly decrease HIF-1α by reducing intracellular and TME hypoxia, thus enhancing X-ray killing of tumor cells. This evidence concerns the gene HIF1A and neoplasm.